When patients present with cardiac symptoms, choosing the right cardiac diagnostic test depends on risk stratification, symptom frequency and clinical context. Here is a practical guide to navigating cardiology testing in primary care, adapted from a continuing medical education presentation by Mostafa O. El-Refai, M.D., interventional cardiologist with Norton Heart & Vascular Institute. Chest pain:…
Sports preparticipation exams are critical opportunities to identify young athletes at risk for sudden cardiac arrest, which is the leading cause of death in young athletes during sports. While sudden cardiac arrest in children is less common than in adults (3 to 8 per 100,000, compared with 52 per 100,000), the stakes remain high when…
Cardiometabolic care is undergoing a transformation that includes the rise of prescribing GLP-1 receptor agonists as multisystem therapeutics. “Treating diabetes, cardiovascular disease and renal or hepatic dysfunction as isolated conditions is now an outdated approach in cardiometabolic care,” said Catrina R. Hancock, PA-C, physician assistant with Norton Heart & Vascular Institute. “Instead, treatment has shifted…
This continuing medical education presentation features Norton Heart & Vascular Institute electrophysiologist Megan E. Gruber, D.O., discussing critical updates in atrial fibrillation (A-fib) treatment based on the latest guideline revisions. Dr. Gruber provides clinicians with practical insights into the evolving approach to A-fib management, including refined classification systems that mirror heart failure staging, enhanced focus…
Dementia care is experiencing a revolutionary shift. For decades, physicians had little to offer patients beyond symptomatic treatments and supportive care. Today, the medical community stands at the edge of a new era — one defined by precise biomarker testing and disease-modifying therapies that represent genuine new treatments for Alzheimer’s disease. Understanding the new treatment…
A groundbreaking clinical trial at Norton Cancer Institute is exploring whether CAR T-cell therapy —a cellular therapy originally developed to treat cancer — could provide a curative treatment for patients with severe autoimmune diseases, including systemic lupus erythematosus (SLE), myositis and scleroderma. The RESOLUTION trial, led by principal investigator Don A. Stevens, M.D., hematologist/oncologist with…
Reviewed by Anupama Raghuram, M.D., and Julio A. Ramirez, M.D. Norton Infectious Diseases Institute researchers are challenging the traditional view of pneumonia as a self- limited acute lung infection, revealing that the disease may be associated with chronic complications affecting multiple organ systems for years after initial diagnosis. Julio A. Ramirez, M.D., and Anupama Raghuram,…